Pharmafit Provence
BEPANTHENE 250 mg/ml S inj 6Amp/2ml

Bayer Healthcare SAS

BEPANTHENE 250 mg/ml S inj 6Amp/2ml

CIP / EAN code: 3400930107089

Product information from VIDAL.

Read the product information

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
SmPC of the 02/07/2026

BEPANTHENE 250 mg/ml, solution for injection I.M.


Forms and presentations

Solution for injection I.M.


Composition

Dexpanthenol (vitamin B5)...................................................................................................................250,0 mg

For 1 ml of injectable solution


Excipients:

Pantolactone, water for injections.



Indications

Adjuvant treatment of diffuse alopecia.



Dosage and administration

Dosage

Reserved for adults.

1 to 2 ampoules by I.M. injection 3 times per week for 6 weeks.

Method of administration

Intramuscular route.



Contraindications

• Hypersensitivity to the active substance or to any of the excipients listed in section Composition.

• Patients suffering from mechanical ileus.



Fertility, pregnancy and breastfeeding

Pregnancy

There is no reliable data on teratogenicity in animals.

In clinical practice, no particular malformative or foetotoxic effect has appeared to date. However, the follow-up of pregnancies exposed to this medicinal product is insufficient to exclude any risk.

Consequently, as a precautionary measure, it is preferable not to use this medicine during pregnancy.

Breast-feeding

In the absence of data, it is preferable not to use this medicine during breastfeeding.



Adverse effects

Undesirable effects are listed below by System Organ Class and by frequency. Frequencies are defined using the following classification: Very common (≥ 1/10); common (≥1/100; < 1/10); uncommon (≥1/1 000; <1/100); rare (≥ 1/10 000; <1/1 000); very rare (< 1/10 000), not known (cannot be estimated from the available data)

Immune system disorders

Very rare: Cutaneous allergic reactions of urticaria type, erythema, Quincke's oedema and bronchospasm

General disorders and administration site conditions

Frequency not known: reaction at the injection site

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: https://signalement.social-sante.gouv.fr/.



Pharmacodynamics

VITAMIN B5 (D: Dermatology).



Shelf life

4 years.



Special storage precautions

To be stored at a temperature not exceeding 25 °C.



Prescription, supply and reimbursement

Marketing authorisation (AMM)
CIP 3400930107089 (6Amp/2ml).
Not reimbursed by Social Security.

Bayer Healthcare SAS
1 RUE CLAUDE BERNARD
59000 LILLE
Tel: 03 28 16 34 00 Tel (toll-free): 08 00 87 54 54
https://www.bayer.fr

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.